Debut Plus

₹569.9

▼ -2.75 -0.48%

17 Jul 2026

NSE Listed · Chemicals

Mangalam Organics Limited (MANORG)

Volume: 3,872Avg Vol 1W: 4,117Avg Vol 1M: 2,20952W Range:₹356.25₹637.85
NSE BSE www.mangalamorganics.com
Key Ratios
Checked just now
Market Cap₹488 Cr
Current Price₹569.9
Previous Close₹572.65
High / Low (52w)₹637.85 / ₹356.25
Volume3,872
Avg Vol (1W)4,117
Avg Vol (1M)2,209
Stock P/E17.15
Book Value₹372
Dividend Yield0%
ROE8.94%
ROA348.2%
Revenue (TTM)—
Revenue Growth7.39%
Profit Margin413.61%
Total Debt₹35 Cr
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹33.24
P/B1.53
Debt / Equity0.78
50 DMA₹540.07
200 DMA₹485.85
Day change-0.48%
Price Chart
₹569.9▲ 24.88% · 1Y
₹622₹3592.4L
2025-11-21
2026-07-17

20-day avg volume: 2K shares

Pros
  • Company is almost debt-free.
  • Net profit is growing year over year.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹118 Cr₹138 Cr₹124 Cr₹150 Cr₹147 Cr₹158 Cr₹164 Cr₹154 Cr
EBITDA₹6 Cr₹7 Cr₹11 Cr₹14 Cr₹20 Cr₹15 Cr₹14 Cr₹16 Cr
Net Profit₹2 Cr₹2 Cr₹4 Cr₹5 Cr₹12 Cr₹3 Cr₹4 Cr₹6 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹376 Cr₹339 Cr₹492 Cr₹493 Cr₹494 Cr₹530 Cr
EBITDA₹78 Cr₹115 Cr₹77 Cr₹-20 Cr₹20 Cr₹38 Cr
Net Profit₹48 Cr₹85 Cr₹54 Cr₹-27 Cr₹4 Cr₹13 Cr
EPS55.5398.8262.68-31.634.9214.6
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹215 Cr₹311 Cr₹560 Cr₹506 Cr₹485 Cr₹624 Cr
Total Liabilities₹47 Cr₹60 Cr₹256 Cr₹230 Cr₹205 Cr₹330 Cr
Equity₹168 Cr₹252 Cr₹304 Cr₹276 Cr₹281 Cr₹293 Cr
Total Debt——————
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹110 Cr₹56 Cr₹-62 Cr₹77 Cr₹69 Cr₹-8 Cr
Investing₹-59 Cr₹-28 Cr₹-100 Cr₹-41 Cr₹-40 Cr₹-67 Cr
Financing₹-36 Cr₹2 Cr₹183 Cr₹-36 Cr₹-33 Cr₹74 Cr
Free Cash Flow₹110 Cr₹56 Cr₹-62 Cr₹77 Cr₹69 Cr₹-8 Cr
Shareholding
Promoter 58.65% Institutions 3.63% Public 37.72%
Efficiency & Working Capital
ROCE9.6%
Interest Coverage1.8
Dividend Payout—
Debtor Days48 d
Inventory Days147 d
Payable Days33 d
Cash Conversion Cycle162 d
Working Capital Days195 d
Shareholding Details

As of 2026-03-31

Promoter58.6%
FII0%
DII3.6%
Institutions3.6%
Public37.7%
Promoter Pledge0%
No. of Shareholders14,560
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters54.9%54.9%54.9%54.9%54.9%58.6%58.6%58.6%58.6%58.6%58.6%58.6%
FIIs0%0%0%0%0%0.1%0%0%0%0%0%0%
DIIs0%0%0%0%0%1.4%1.4%1.4%2.8%3.6%3.6%3.6%
Public45.1%45.1%45.1%45.1%45.1%39.8%39.9%39.9%38.6%37.7%37.7%37.7%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders21,01320,52320,01619,52719,01018,11717,82117,56116,83716,36115,01014,560
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Tradechem Organics LimitedShareholding of Promoter and Promoter Group21.4%18,29,417
Manisha Pankaj DujodwalaShareholding of Promoter and Promoter Group10%8,53,250
Akshay DujodwalaShareholding of Promoter and Promoter Group9.4%8,07,965
Alka K DujodwalaShareholding of Promoter and Promoter Group6.8%5,78,790
Kamalkumar Ramgopal DujodwalaShareholding of Promoter and Promoter Group5.6%4,77,340
Radhakishan S DamaniPublic Shareholding2.2%1,86,187
Niveshaay Hedgehogs FundPublic Shareholding2.1%1,81,191
Dujodwala Exports Private LimitedShareholding of Promoter and Promoter Group2%1,72,432
Dujodwala Pankaj RamgopalShareholding of Promoter and Promoter Group2%1,72,432
Pannkaj DujodwalaShareholding of Promoter and Promoter Group1.5%1,31,300
Rational Equity Trust-rational Equity Flagship Fund IPublic Shareholding1.4%1,21,400
Vasudha DujodwalaShareholding of Promoter and Promoter Group0%0
Ramgopal Kamalkumar DujodwalaShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Manisha Pankaj Dujodwala00%2026-03-31
Akshay Dujodwala00%2026-03-31
Alka K Dujodwala00%2026-03-31
Kamalkumar Ramgopal Dujodwala00%2026-03-31
Dujodwala Pankaj Ramgopal00%2026-03-31
Pannkaj Dujodwala00%2026-03-31
Vasudha Dujodwala00%2026-03-31
Ramgopal Kamalkumar Dujodwala00%2026-03-31
Tradechem Organics Limited00%2026-03-31
Dujodwala Exports Private Limited00%2026-03-31
Niveshaay Hedgehogs Fund00%2026-03-31
Rational Equity Trust-rational Equity Flagship Fund I00%2026-03-31
Board of Directors
NameDesignationYear
Kamalkumar DujodwalaExecutive Chairman2025
Pannkaj DujodwalaED / MD / Promoter2025
Manisha AgarwalIndependent Non Exe. Director2025
Sanjay Bhiva KadamIndependent Non Exe. Director2025
Sidharath Singh SekhonIndependent Non Exe. Director2025
Mahesh Lahurao NavatharExecutive Director (Works)2025
Sudarshan Kumar SarafIndependent Non Exe. Director2025
Charmi ShahCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Manufacturing of Chemicals₹0 Cr—
Segments — Geography
RegionRevenueShare
Local Sales₹360 Cr89.6%
Export Sales₹42 Cr10.4%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹101299
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20259000128110
202500012820
202590000090
Insider / Designated-Person Trades

1 recent disclosure(s)

KAMALKUMAR DUJODWALAAcquisition · 3,20,124
Substantial Acquisitions (SAST)

1 disclosure(s)

Market02/09/2024 · 3,20,124
Company Information
Incorporated1981
ChairmanKamalkumar Dujodwala
AuditorNGST & Associates
Investor Email[email protected]
🌐 www.mangalamorganics.com ↗

📍 Kumbhivali Vill Taluk Khalapur, Savroli Kharpada Road Khapoli, Raigad, Maharashtra, 410202

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Manilam Industries Ind LimitedMan Industries (I) Ltd.Man Infra Ltd.Mankind Pharma LimitedManomay Tex India Ltd.Manorama Industries Ltd.ManugraphVedant Fashions LimitedCE Info Systems LimitedMaral Overseas Ltd.Marathon Nxtgen Realt Ltd.Marc Technocrats LimitedAll “M” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search